Difference in finger, earlobe, and forehead oxygen levels to predict outcomes in dyspnea
Official title: Prognostic Significance of Multi-site Pulse Oximetry Differences in Dyspneic Emergency Department Patients
Run by Yonsei University · NCT07824414 · Data updated 2026-11-12
In adults with breathing trouble, this study tests whether differences in SpO2 readings from different body sites can predict who might have worse outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 19 Years and up |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | Yonsei University Academic / other |
| Locations | 1 site (Seoul, Seoul) |
| Status | Recruiting |
| Started | May 29, 2026 |
| Main results expected | March 31, 2027 |
| Study ends | April 30, 2027 |
| Registry record updated | September 17, 2026 |
| Trial ID | NCT07824414 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 19 years or older presenting to ED with dyspnea and KTAS levels 1-3.
✕Probably not a fit
Patients who do not show differences in SpO2 between sites or who do not experience poor outcomes may not derive predictive benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective observational study enrolls adults (≥19) with dyspnea presenting to a single emergency department. SpO2 is measured simultaneously at the finger, earlobe, and forehead, along with perfusion indices, to calculate inter-site differences (ΔSpO2). The primary outcome compares mean ΔSpO2 between patients who experience poor outcomes (death or ICU admission) and those with favorable outcomes. Secondary analyses assess associations with mortality, ICU admission, the need for intubation, lactate, and perfusion index, and compare predictive performance against established early warning scores. Data are collected at presentation and outcomes are obtained from medical records; analyses include logistic regression and ROC methods. The study is led by Yonsei University at Yonsei University Severance Hospital in Seoul, Korea, and focuses on adult dyspnea patients admitted with KTAS levels 1-3.
Why it matters
Potential benefit: If successful, ΔSpO2 measurements could help clinicians identify high-risk dyspnea patients earlier and tailor monitoring and interventions.
How similar studies have gone: This is a prospective approach building on prior interest in multi-site SpO2 differences for prognosis, with ongoing evaluation against early warning scores.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients aged 19 years or older presenting to the emergency department with dyspnea, classified as KTAS level 1-3 Exclusion Criteria: * Patients in whom SpO₂ measurements were not obtained simultaneously * Patients in whom arterial blood gas analysis was not ordered at initial evaluation * Pregnant patients * Patients with facial trauma or hand trauma * Patients with amputation, injury, or burns at the measurement sites * Patients wearing nail polish * Patients with dyshemoglobinemia * Non-Korean nationality * Patients who did not provide consent to participate in the study
Where it's running
-
Yonsei University Severance Hospital
Seoul, Seoul, South Korea Recruiting
Study contacts
- Study coordinator: Stephen GW LEE, MD
- Email: leestephengyungwon@yuhs.ac
- Phone: 82-10-5124-8415
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pulmonary and cardiovascular rehabilitation program for chronic respiratory and heart conditions
This study tests a rehabilitation program that combines exercise for people with chronic lung and heart conditions to see if it helps them feel better and improve their daily activities.
-
Assessing diaphragm function in patients with respiratory diseases
This study is testing how well the diaphragm works in people with respiratory diseases to see if it affects their breathing difficulties and overall health.
-
Wintergreen oil inhalation for shortness of breath in pneumonia patients
Hospitals will test whether inhaling wintergreen essential oil helps relieve dyspnea in adults with pneumonia.
-
See if video telemedicine with a caller’s mobile camera improves care for adults with acute dyspnea
This study tests whether adding video calls from a caller’s mobile phone to the emergency dispatch process helps improve care for adults with acute shortness of breath.
-
CardioStory device in helping tell heart failure from other causes in people with shortness of breath
This study tests whether the CardioStory noninvasive device can help emergency department clinicians distinguish heart failure from other causes of dyspnea in adults.
-
Normal lung and heart function references for healthy US veterans who served in Southwest Asia
This study tests whether healthy veterans aged 24–68 who did not have exposure to airborne hazards have normal lung and heart function values that can serve as reference standards.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.